Climb Bio (CLYM) Times Interest Earned (2020 - 2026)
Climb Bio (CLYM) posted Times Interest Earned of -$0.47 for Q1 2026, up 71.43% on a QoQ basis from -$1.65 in Q4 2025, and up 98.91% year-over-year from -$0.24 in Q1 2025.
Climb Bio (CLYM) Times Interest Earned (2020 - 2026) Analysis & Trends
Climb Bio's Times Interest Earned history runs 7 years deep, the most recent figure standing at -$0.47 for Q1 2026.
- Quarterly Times Interest Earned rose 98.91% year-over-year to -$0.47 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.86 (up 99.03% YoY) and the FY2025 annual result came in at -$5.79, down 101.08% from the prior year.
- Times Interest Earned was -$0.47 for Q1 2026 at Climb Bio, up from -$1.65 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.25 in Q4 2023 and bottomed at -$296.58 in Q2 2025.
- A 5-year average of -$26.7 and a median of -$3.48 in 2022 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2024 — Times Interest Earned plunged 17671.17% — and 2026, when it surged 98.91%.
- Climb Bio's Times Interest Earned stood at -$0.57 in 2022, then surged by 56.92% to -$0.25 in 2023, then plunged by 17671.17% to -$43.64 in 2024, then jumped by 96.23% to -$1.65 in 2025, then soared by 71.43% to -$0.47 in 2026.
- Business Quant data shows CLYM's Times Interest Earned at -$0.47 in Q1 2026, -$1.65 in Q4 2025, and -$9.27 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - | -0.47 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.47 |
| Dec 31, 2025 | -1.65 |
| Sep 30, 2025 | -9.27 |
| Jun 30, 2025 | -296.58 |
| Mar 31, 2025 | -43.10 |
| Dec 31, 2024 | -43.64 |
| Sep 30, 2024 | -12.52 |
| Jun 30, 2024 | -20.22 |
| Mar 31, 2024 | -2.80 |
| Dec 31, 2023 | -0.25 |
| Sep 30, 2023 | -3.80 |
| Jun 30, 2023 | -3.01 |
| Mar 31, 2023 | -9.61 |
| Dec 31, 2022 | -0.57 |
| Sep 30, 2022 | -2.04 |
| Jun 30, 2022 | -3.48 |
| Mar 31, 2022 | -0.82 |
| Dec 31, 2021 | -0.51 |
| Sep 30, 2021 | -0.22 |
| Jun 30, 2021 | -0.37 |